
MIKU CARE Chosen TO JOIN THE WEST COAST CONSORTIUM FOR Technologies & INNOVATION IN PEDIATRICS (CTIP)
WOODBRIDGE, N.J., March 28, 2023 /PRNewswire/ — Miku Care (Miku), the technologies enterprise that revolutionized the pediatric wellness space applying a contactless respiratory & sleep monitoring method, announced these days that it has been chosen to join The West Coast Consortium for Technologies & Innovation in Pediatrics (CTIP), a pediatric healthcare device accelerator centered at Children’s Hospital Los Angeles (CHLA) and the University of Southern California (USC) that promotes the commercialization and clinical use of pediatric healthcare device technologies.
Miku Care x CTIP
“We are honored to be recognized by CTIP and earn a spot alongside some of the world’s most revolutionary healthcare corporations,” mentioned Johann Fernando, Ph.D., Chief Executive Officer at Miku Care. “By means of this partnership with CTIP, Miku gains a sturdy ally equally devoted to innovation and improvement of pediatric healthcare devices.”
Miku Care is presently created for parents and caregivers, providing a sleep monitoring remedy that comes with intuitive displays and analytics that make it straightforward for parents to recognize their child’s sleep and respiratory behaviors and trends, all with out the use of a wearable accessory. Miku is not presently provided or intended for diagnostic use.
Miku’s wearable-totally free monitoring technologies has the prospective to lower usage concerns and monitoring obstructions by eliminating the need to have for wearing, charging, or cleaning a wearable solution. Beyond wearables, SensorFusion® technologies also has the prospective to overcome the challenges of current camera-only or below-mattress merchandise. In scenarios with blankets, obstructions, and shadows in a crib or bed of any size, Miku continues to supply monitoring coverage for caretakers.
“Pediatric healthcare device innovation lags behind adults by ten-15 years—this is a significant inequity in healthcare. CTIP is committed to addressing this by identifying and supporting the improvement of prospective pediatric healthcare devices by innovators like Miku from notion to commercialization,” mentioned Dr. Juan Espinoza, Director and Principal Investigator at CTIP.
In 2022, Miku Care in collaboration with Boston Children’s Hospital announced a very first-of-its-type epilepsy investigation study applying an investigational monitoring device. This investigation aims to monitor and in the end detect generalized tonic-clonic seizures, which happen in 25% of all individuals with seizures and are the most frequent kind of generalized seizure in adults. These seizures are also a significant danger aspect for sudden unexpected death in epilepsy (SUDEP). The Institutional Overview Board (IRB)-authorized study aims to capture generalized tonic-clonic seizure events on study participants. Individuals will be monitored by Miku Care’s SensorFusion® technologies, and simultaneously, a video-EEG method, the business-regarded “gold typical” of hospital monitoring.
The study is presently underway, supplying hope to parents and caregivers of loved ones. With this investigation, Miku aims to obtain insight into detecting generalized tonic-clonic seizures in a residence setting applying its speak to-totally free sensing technologies, as properly as the capacity to predict seizure activity prior to it happens primarily based on longitudinal wellness trends in respiration, heart price, and sleep, combined with the patient’s history of seizures. The information collected is intended to advance the wellness and wellbeing of youngsters and help a prospective marketing and advertising application.
“Our devoted group at Miku has spent years focusing on establishing revolutionary technologies to advance pediatric care,” mentioned Eric White, Co-founder and Chief Solution & Technologies Officer at Miku Care. “We are excited to companion with CTIP and think that by operating collectively we will generate and expand possibilities as properly as lead future developments.”
To understand extra, check out https://mikucare.com/.
About The West Coast Consortium for Technologies & Innovation in Pediatrics (CTIP)
The West Coast Consortium for Technologies & Innovation in Pediatrics (CTIP) is an FDA-funded pediatric MedTech accelerator centered at Children’s Hospital Los Angeles. Our target is to facilitate the improvement, production, and distribution of pediatric healthcare devices by identifying corporations operating in the space and supplying assistance, networking, and direct and indirect economic help on the road to commercialization. Discover extra at https://www.westcoastctip.org/
About Miku Care
Miku Care is a pediatric wellness monitoring enterprise producing merchandise that make it straightforward for parents to recognize their child’s sleep and respiratory behaviors and trends. The speak to-totally free Miku Pro Sensible Child Monitor and corresponding analytics platform give parents straightforward access to breathing and sleep information, all with out the use of a wearable. Miku sensible child monitors are presently not provided or intended to diagnose, remedy, mitigate, avoid, or treat any illness or situation and are not authorized or cleared by FDA.
Founded in 2018, Miku Care’s merchandise and proprietary, clinically tested SensorFusion™ technology have received accolades from Quick Organization, CES, Superior Housekeeping, Babylist, Digital Trends, and extra for innovation, design and style, and all round business greatest-of. Partnered with established universities, hospital systems, investigation organizations, investors, and leaders, Miku is pioneering contactless monitoring in the pediatric space. For extra details, please visit mikucare.com. Stick to us on Instagram, Facebook, Twitter and LinkedIn.
Supply Miku